Company page

Nanobiotix Sa

Nanobiotix Sa is a public company listed under the ticker NANO on the French market. The company has a market capitalization of approximately €1.76 billion. Nanobiotix focuses on developing innovative cancer treatments through nanomedicine.

profileNANO:EURONEXTAI content: aiUpdated June 24, 2026/company/nanobiotix-sa-1/c-bnxkjsdt
Nanobiotix Sa logo
Ticker
NANO:EURONEXT
Asset type
Stock
Market cap
$1.76B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR